Gamma-emitting receptor-binding 3-quinuclidinyl glycolates; meth

Details Gamma-emitting receptor-binding 3-quinuclidinyl glycolates; meth Gamma-emitting receptor-binding 3-quinuclidinyl glycolates; meth

1981-12-31

1984-02-14

Nucker, Christine M.

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

424 9, 436542, 436545, 546137, A61K 4900, A61K 4300, C07D45302, G01N 3354

Patent

active

044316275

ABSTRACT:
Compounds of the formula: ##STR1## wherein R is aryl, alkyl, cycloalkyl, phenyl, cyclopentyl, cyclohexyl, a ligand containing Tc-99m in chelated form or a ligand capable of chelating Tc-99m;

REFERENCES:
patent: 3405134 (1968-10-01), Judd
patent: 3714357 (1973-01-01), Gueremy et al.
patent: 3833592 (1974-09-01), Papanastassiou et al.
patent: 3910929 (1975-10-01), Breslow
patent: 4017596 (1977-04-01), Loberg et al.
patent: 4082756 (1978-04-01), Bauman
patent: 4360511 (1982-11-01), Baldwin et al.
patent: 4363793 (1982-12-01), Blau et al.
Proceedings of the First International Pharmacological Meeting, vol. 7, Ed. Brunings et al., Pergamon Press, N.Y. 1963, pp. 360-366.

Affiliated with

Also associated with

Rating

Gamma-emitting receptor-binding 3-quinuclidinyl glycolates; meth does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Gamma-emitting receptor-binding 3-quinuclidinyl glycolates; meth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gamma-emitting receptor-binding 3-quinuclidinyl glycolates; meth will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2374718